H. Herr

发表

Combined chemotherapy and surgery in treatment of advanced germ‐cell tumors

M. Bains, W. Whitmore, P. Sogani, 1981, Cancer.

Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors

D. Bajorin, G. Bosl, A. Aprikian, 1994, Cancer.

Detection and follow‐up of carcinoma of the urinary bladder by flow cytometry

M. Melamed, W. Whitmore, P. Sogani, 1982, Cancer.

Antigrowth effect of polyamine biosynthesis inhibitors on the dunning R 3327‐G prostatic tumor

H. Herr, Edward L. Kleinert, 1984, The Prostate.

Monitoring intravesical bacillus Calmette‐Guerin treatment of superficial bladder carcinoma by serial flow cytometry

M. Melamed, R. Badalament, W. Fair, 1986, Cancer.

Intravesical BCG: Current results, natural history and implicants for urothelial cancer prevention

H. Herr, H. Herr, 1992, Journal of cellular biochemistry. Supplement.

Quality of life measurement in testicular cancer patients

H. Herr, H. Herr, 1987, Cancer.

Association of depressed mixed lymphocyte reactivity with the development of bladder carcinoma in patients with papillomas

H. Herr, 1983, Cancer.

Idiographic quality of life assessment before radical cystectomy

V. Laudone, B. Rapkin, B. Bochner, 2017, Psycho-oncology.

The effect of gender on response to bacillus Calmette‐Guérin therapy for patients with non‐muscle‐invasive urothelial carcinoma of the bladder

S. Boorjian, F. Zhu, H. Herr, 2010, BJU international.

Estrogen, progesterone, and androgen‐binding sites in renal cell carcinoma. Observations obtained in phase II trial of flutamide

H. Scher, W. Whitmore, P. Sogani, 1984, Cancer.

Correlation of histochemical and biochemical analyses of androgen binding in prostatic cancer: Relation to therapeutic response

W. Whitmore, J. Karr, H. Rosenthal, 1982, Cancer.

Standardization of radical cystectomy: Time to count and be counted

J. Montie, Joseph A. Smith, H. Herr, 2004, BJU international.

NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022.

A. Kishan, V. Margulis, S. Boorjian, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

Immunologic reactivity of lymph nodes regional to prostatic cancer: Preliminary observations

H. Herr, 1977, Journal of surgical oncology.

Potentiation of methylglyoxal‐bis‐guanylhydrazone by alpha‐difluoromethylornithine in rat prostate cancer

W. Whitmore, Willet F. Whitmore, H. Herr, 1984, Cancer.

High‐risk, high‐grade (T1G3) bladder cancer

H. Herr, 2009, Cancer.

Evaluating the utility of a preoperative nomogram for predicting 90‐day mortality following radical cystectomy for bladder cancer

M. Bernstein, A. Feifer, S. Donat, 2012, BJU international.

Endoscopic diagnosis and treatment of upper‐tract urothelial tumors. A preliminary report

W. Whitmore, D. Bagley, J. Huffman, 1985, Cancer.

Intravesical bacille Calmette‐Guérin (BCG) in immunologically compromised patients with bladder cancer

G. Dalbagni, H. Herr, 2013, BJU international.

The sensitivity of flow cytometry compared with conventional cytology in the detection of superficial bladder carcinoma

M. Melamed, M. Kimmel, R. Badalament, 1987, Cancer.

Lymph node density for patient counselling about prognosis and for designing clinical trials of adjuvant therapies after radical cystectomy

C. Dinney, M. Munsell, A. Kamat, 2012, BJU international.

Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma

A. Hakimi, H. Vargas, J. Coleman, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

‘Crushing the stone’: a brief history of lithotripsy, the first minimally invasive surgery

H. Herr, 2008, BJU international.

Reduced bladder tumour recurrence rate associated with narrow‐band imaging surveillance cystoscopy

H. Herr, S. Donat, H. Herr, 2011, BJU international.

Uretero‐enteric stricture outcomes: secondary analysis of a randomised controlled trial comparing open versus robot‐assisted radical cystectomy

V. Laudone, J. Coleman, A. Vickers, 2022 .

The enlarged prostate: a brief history of its surgical treatment

H. Herr, H. Herr, 2006, BJU international.

Evaluation of Drug Delivery and Survival Impact of Dose-Intense Relative to Conventional-Dose Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Chemotherapy in Urothelial Cancer

M. Mazumdar, H. Scher, D. Bajorin, 2000, Cancer investigation.

Strategies for the management of recurrent and advanced urologic cancers. Quality of life

H. Herr, H. Herr, 1987, Cancer.

Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy

A. Hakimi, D. Sjoberg, P. Kim, 2014, BJU international.

The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The memorial sloan‐kettering cancer center experience

P. Russo, W. Fair, W. Whitmore, 1994, Cancer.

An evaluation of automated flow cytometry (FCM) in detection of carcinoma in situ of the urinary bladder

M. Melamed, W. Whitmore, P. Sogani, 1982, Cancer.

Does cystoscopy correlate with the histology of recurrent papillary tumours of the bladder?

H. Herr, 2001, BJU international.

Bladder cancer in cystoscopically normal‐appearing mucosa: a case of mistaken identity?

V. Reuter, H. Al-Ahmadie, G. Dalbagni, 2010, BJU international.

The patient, disease status, and treatment options for prostate cancer: Stages B1 and B2

H. Herr, 1983, The Prostate.

GOAT GLANDS REJUVENATED

H. Herr, H. Herr, 2009, BJU international.

VAB‐6 combination chemotherapy in resected stage II‐B testis cancer

W. Whitmore, Davor Vugrin, H. Herr, 1983, Cancer.

Significance of prostatic biopsies after radiation therapy for carcinoma of the prostate

W. Whitmore, H. Herr, 1982, The Prostate.

V. Laudone, J. Coleman, A. Vickers, 2023, The Journal of urology.

Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology.

B. Bochner, A. Shabsigh, G. Raj, 2009, European urology.

Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium.

N. Geller, H. Scher, C. Sternberg, 1985, The Journal of urology.

Penile cancer: relation of extent of nodal metastasis to survival.

W. Whitmore, P. Sogani, H. Herr, 1987, The Journal of urology.

Partial nephrectomy for unilateral renal carcinoma and a normal contralateral kidney: 10-year followup.

H. Herr, H. Herr, 1999, The Journal of urology.

The value of a second transurethral resection in evaluating patients with bladder tumors.

H. Herr, H. Herr, Harry W. Herr, 2000, The Journal of urology.

Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression.

V. Laudone, David A. Amato, R. Badalament, 1989, The Journal of urology.

The sensitivity of flow cytometry compared with conventional cytology in the detection of superficial bladder carcinoma

M. Melamed, R. Badalament, W. Fair, 1987, Cancer.

Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression.

C. Cordon-Cardo, V. Reuter, Zuo-Feng Zhang, 1993, Journal of the National Cancer Institute.

Can p53 help select patients with invasive bladder cancer for bladder preservation?

C. Cordon-Cardo, V. Reuter, H. Scher, 1999, The Journal of urology.

Flow cytometry as a predictor of response and progression in patients with superficial bladder cancer treated with bacillus Calmette-Guerin.

M. Melamed, M. Kimmel, W. Fair, 1989, The Journal of urology.

Monitoring intravesical bacillus Calmette-Guerin treatment of bladder carcinoma with flow cytometry.

M. Melamed, Z. Darżynkiewicz, W. Whitmore, 1985, The Journal of urology.

Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy.

M. Mazumdar, H. Scher, D. Bajorin, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy.

H. Herr, M. O'Sullivan, H. Herr, 2000, The Journal of urology.

Updated concepts and treatment of carcinoma in situ.

D. Lamm, F. Mostofi, I. Sesterhenn, 1998, Urologic oncology.

M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium.

N. Geller, N. Bander, H. Scher, 1988, The Journal of urology.

Surgical factors influence bladder cancer outcomes: a cooperative group report.

H. Grossman, R. deVere White, E. Crawford, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hodgkin's disease of the prostate: a detailed case report.

L. Klotz, H. Herr, H. Herr, 1986, The Journal of urology.

Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?

P. Sogani, H. Herr, H. Herr, 2001, The Journal of urology.

Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens.

V. Reuter, B. Bochner, H. Herr, 2001, The Journal of urology.

Radical cystectomy in octogenarians--does morbidity outweigh the potential survival benefits?

M. Milowsky, C. Savage, H. Herr, 2009, The Journal of urology.

Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.

S. Boorjian, N. Agarwal, Sam S. Chang, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

Pelvic lymph node dissection can be curative in patients with node positive bladder cancer.

W. Fair, J. Vieweg, J. Gschwend, 1999, The Journal of urology.

An overview of intravesical therapy for superficial bladder tumors.

V. Laudone, W. Whitmore, H. Herr, 1987, The Journal of urology.

Clinical stage I testis cancer: long-term outcome of patients on surveillance.

H. Thaler, W. Fair, G. Bosl, 1998, The Journal of urology.

NCCN Guidelines Insights: Bladder Cancer, Version 5.2018.

Anthony Patterson, Mark K Buyyounouski, Khurshid A Guru, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

Male urethral carcinoma: analysis of treatment outcome.

L. Lacombe, G. Dalbagni, Z. F. Zhang, 1999, Urology.

Adult urological sarcoma.

P. Russo, W. Fair, M. Brennan, 1992, The Journal of urology.

Surgery for a post-chemotherapy residual mass in seminoma.

R. Motzer, D. Bajorin, G. Bosl, 1997, The Journal of urology.

Management of low grade papillary bladder tumors.

V. Reuter, H. Herr, S. Donat, 2007, The Journal of urology.

Endocrine and exocrine profiles of men with testicular tumors before orchiectomy.

P. Carroll, W. Fair, R. Chaganti, 1987, The Journal of urology.

Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors.

R. Motzer, W. Fair, G. Bosl, 1992, The Journal of urology.

Positive surgical margins at partial nephrectomy: predictors and oncological outcomes.

Paul Russo, P. Russo, R. Thompson, 2008, The Journal of urology.

The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin.

A. Hakimi, P. Kim, J. Sfakianos, 2014, The Journal of urology.

Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome.

H. Herr, H. Herr, 2000, The Journal of urology.

NCCN Guidelines Insights: Bladder Cancer, Version 5.2018.

Geoffrey E. Wile, S. Boorjian, N. Agarwal, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

Does necrosis on frozen-section analysis of a mass after chemotherapy justify a limited retroperitoneal resection in patients with advanced testis cancer?

H. Herr, H. Herr, 1997, British journal of urology.

Association of P53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder.

C. Cordon-Cardo, V. Reuter, J. Melamed, 1994, The Journal of urology.

Extravesical tumor relapse in patients with superficial bladder tumors.

H. Herr, H. Herr, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Is biopsy of the contralateral testis necessary in patients with germ cell tumors?

J. Sheinfeld, H. Herr, H. Herr, 1997, The Journal of urology.

Safety and efficacy of intravesical bacillus Calmette-Guérin instillations in steroid-treated and immunocompromised patients.

B. Bochner, S. Eggener, G. Dalbagni, 2006, Journal of Clinical Oncology.

Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?

G. Dalbagni, H. Herr, S. Donat, 2007, The Journal of urology.

Defining optimal therapy for muscle invasive bladder cancer.

D. Bajorin, H. Herr, Z. Dotan, 2007, The Journal of urology.

Adherence to surveillance guidelines after radical cystectomy: a population-based analysis.

Coral L. Atoria, W. Lowrance, E. Elkin, 2014, Urologic oncology.

Defining optimal therapy for muscle invasive bladder cancer.

D. Bajorin, Z. Dotan, S. Donat, 2007, The Journal of urology.

Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial.

W. Fair, W. Whitmore, Z. F. Zhang, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome.

H. Scher, D. Bajorin, H. Herr, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology.

B. Bochner, A. Shabsigh, G. Raj, 2009, European urology.

Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection.

Paul Russo, P. Russo, B. Bochner, 2004, The Journal of urology.

Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer.

D. Bajorin, H. Herr, S. Donat, 2001, The Journal of urology.

Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy.

H. Herr, S. Donat, S. Donat, 2001, The Journal of urology.

Surgical treatment of brain metastases from renal cell carcinoma.

R. Badalament, W. Fair, H. Herr, 1990, Urology.

Civiale, stones and statistics: the dawn of evidence‐based medicine

H. Herr, 2009, BJU international.

Mortality in pediatric paratesticular rhabdomyosarcoma: a multivariate analysis.

G. Heller, M. LaQuaglia, S. Hajdu, 1989, The Journal of urology.

Bladder cancer: advances in biology and treatment.

C. Cordon-Cardo, V. Reuter, H. Scher, 1994, Critical reviews in oncology/hematology.

Bacillus Calmette-Guerin therapy for superficial bladder cancer: a 10-year followup.

W. Fair, H. Oettgen, H. Herr, 1992, The Journal of urology.

Conservative management of muscle-infiltrating bladder cancer: prospective experience.

H. Herr, H. Herr, 1987, The Journal of urology.

Partial nephrectomy for a renal oncocytoma associated with tuberous sclerosis.

H. Herr, E. Hajdu, V. Srinivas, 1985, The Journal of urology.

Adult UrologyOncology: Adrenal/Renal/Upper Tract/BladderPositive Surgical Margins at Partial Nephrectomy: Predictors and Oncological Outcomes

P. Russo, B. Leibovich, M. Blute, 2008 .

The management of patients with nonseminomatous germ cell tumors of the testis with serologic disease only after orchiectomy.

W. Fair, G. Bosl, H. Herr, 1994, The Journal of urology.

The T1 bladder tumor.

J. Sheinfeld, G. Jakse, H. Herr, 1990, Seminars in urology.

Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma.

S. Tickoo, G. Iyer, H. Al-Ahmadie, 2018, Human pathology.

Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. 1 1 H. Barton Grossman, M.D

V. Reuter, B. Bochner, D. Bajorin, 2002 .

Quality of life of incontinent men after radical prostatectomy.

H. Herr, H. Herr, 1994, The Journal of urology.

Clinical outcome of primary versus secondary bladder carcinoma in situ.

B. Bochner, S. Shariat, G. Dalbagni, 2010, The Journal of urology.

Urachal carcinoma: the case for extended partial cystectomy.

H. Herr, H. Herr, 1994, The Journal of urology.

The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer.

H. Herr, S. Donat, M. McGuire, 2001, The Journal of urology.

Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder.

M. Melamed, W. Whitmore, H. Oettgen, 1986, The Journal of urology.

Does current chemotherapy improve survival of patients with invasive bladder cancer?

H. Herr, H. Herr, 1997, Urology.

Anticarcinoma activity of rhodamine 123 against a murine renal adenocarcinoma.

M. Melamed, H. Herr, J. Huffman, 1988, Cancer research.

Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder.

V. Reuter, D. Sjoberg, H. Al-Ahmadie, 2013, The Journal of urology.

Bladder Cancer, Version 3.2024.

A. Kishan, E. Plimack, K. Guru, 2024, Journal of the National Comprehensive Cancer Network : JNCCN.

Residual mass after chemotherapy for seminoma: changing concepts of management.

G. Bosl, H. Herr, H. Herr, 1987, The Journal of urology.

Transurethral resection and intravesical therapy of superficial bladder tumors.

H. Herr, H. Herr, 1991, The Urologic clinics of North America.

Correlation of cystoscopy with histology of recurrent papillary tumors of the bladder.

G. Dalbagni, H. Herr, S. Donat, 2002, The Journal of urology.

Prostatic tumor relapse in patients with superficial bladder tumors: 15-year outcome.

H. Herr, S. Donat, H. Herr, 1999, The Journal of urology.

Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study.

P. Kantoff, P. Scardino, J. Eastham, 2004, The Journal of urology.

Transurethral resection of muscle-invasive bladder cancer: 10-year outcome.

H. Herr, H. Herr, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.

N. Schultz, M. Berger, G. Iyer, 2019, European urology.

Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer.

W. Lowrance, David S. Yee, B. Bochner, 2010, The Journal of urology.

Clinical outcomes of primary bladder carcinoma in situ in a contemporary series.

B. Bochner, S. Shariat, G. Dalbagni, 2010, The Journal of urology.

Tumour progression and survival in patients with T1G3 bladder tumours: 15-year outcome.

H. Herr, H. Herr, 1997, British journal of urology.

Selection of testicular tumor patients for omission of retroperitoneal lymph node dissection.

W. Fair, W. Whitmore, P. Sogani, 1986, The Journal of urology.

Overexpression of p53 protein in a high-risk population of patients with superficial bladder cancer before and after bacillus Calmette-Guérin therapy: correlation to clinical outcome.

C. Cordon-Cardo, V. Reuter, L. Lacombe, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma.

M. Kattan, P. Russo, B. Bochner, 2004, The Journal of urology.

Positive urinary cytology following a complete response to intravesical bacillus Calmette-Guerin therapy: pattern of recurrence.

P. Russo, W. Fair, J. Sheinfeld, 1994, The Journal of urology.

Outpatient flexible cystoscopy and fulguration of recurrent superficial bladder tumors.

H. Herr, H. Herr, 1990, The Journal of urology.